ARTICLE | Company News
Life Technologies, Harvard deal
March 11, 2013 7:00 AM UTC
Life Technologies received exclusive, worldwide rights from Harvard to develop a panel of characterization assays to rapidly evaluate human pluripotent stem (hPS) cells for discovery and translational research applications. Life Technologies said the panel will be offered on the company's semiconductor sequencing and PCR-based genetic analysis technologies. Life Technologies declined to disclose details, while Harvard could not be reached. ...